|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Ovid Therapeutics (NASDAQ: OVID) through any online brokerage.
There are no as such competitors for Ovid Therapeutics.
The latest price target for Ovid Therapeutics (NASDAQ: OVID) was reported by Citigroup on 2020-12-02. The analyst firm set a price target for 4.00 expecting OVID to rise to within 12 months (a possible 3.90% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Ovid Therapeutics (NASDAQ: OVID) is $3.85 last updated Wed Apr 14 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Ovid Therapeutics.
There is no upcoming split for Ovid Therapeutics.